PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Toutain Stephan
May 2 16:23 ET
PDS Biotechnology | 3: Initial statement of beneficial ownership of securities-Officer Toutain Stephan
May 2 16:21 ET
PDS Biotechnology | 8-K: Current report
May 2 06:08 ET
PDS Biotechnology | ARS: Annual Report to Security Holders
Apr 29 07:28 ET
PDS Biotechnology | DEFA14A: Others
Apr 29 07:18 ET
PDS Biotechnology | DEF 14A: Definitive information statements
Apr 29 07:08 ET
PDS Biotechnology | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 18 16:18 ET
PDS Biotechnology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 28 17:32 ET
PDS Biotechnology | 10-K: Annual report
Mar 28 17:22 ET
PDS Biotechnology | 8-K: Current report
Mar 27 07:34 ET
PDS Biotechnology | 8-K: Current report
Mar 13 06:08 ET
PDS Biotechnology | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.0%)
Jan 29 17:30 ET
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Shepard Kirk V.
Jan 23 00:00 ET
PDS Biotechnology | 3: Initial statement of beneficial ownership of securities-Officer Shepard Kirk V.
Jan 23 00:00 ET
PDS Biotechnology | 8-K: Current report
Jan 22 00:00 ET
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Boesgaard Lars
Dec 4, 2023 18:14 ET
PDS Biotechnology | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Boesgaard Lars
Dec 4, 2023 18:11 ET
PDS Biotechnology | 8-K: Current report
Dec 4, 2023 16:02 ET
PDS Biotechnology | 8-K: Current report
Nov 28, 2023 06:02 ET
PDS Biotechnology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Nov 14, 2023 16:11 ET
No Data
No Data